In our previous study, PEG-g-PLA nanoparticles were developed and characterized. The aim of the present work is to investigate the effect of PEG grafting density (% PEG inserted onto poly( d, l)-lactide, PLA backbone) on both physicochemical and biological properties (mainly plasma protein binding and in vitro macrophage uptake) of PEG-g-PLA NPs. Rhodamine B (RHO) loaded NPs were prepared from a 1:1 (wt/wt) blend of PLA and PEG-g-PLA copolymer of varying PEG grafting density (1, 7, or 20% mol/mol of lactic acid monomer) by an o/w emulsion solvent evaporation method. These NPs were characterized with regard to their morphology, size, surface charge, loading efficiency, and rhodamine release. The extent of protein adsorption to the surface of different NPs was qualitatively investigated by dynamic light scattering technique. Additionally, the in vitro macrophage uptake following incubation of RAW 264.7 cells with rhodamine loaded PEG-g-PLA and PLA particles was investigated by confocal laser scanning microscopy (CLSM). The amount of NPs phagocytosed following incubation of RAW 264.7 cells with different concentrations of rhodamine loaded PLA or pegylated NPs for 24 h at 37 °C was also determined by fluorescence spectroscopy. ALL lyophilized NPs showed larger diameter in the range of 300–400 nm compared to freshly prepared NPs suspension indicating particle aggregation upon lyophilization. % EE of rhodamine was found to be between 10% and 68% wt/wt depending on PEG grafting density. The higher the grafting density of PEG over PLA backbone, the more the entrapment efficiency. All pegylated NPs showed low zeta potential (close to zero) values. In vitro release analysis revealed that rhodamine leaked from all nanoparticles at a very slow rate at physiological pH, thus making it suitable for both imaging and uptake studies with RAW 264.7 cells. All PEG-g-PLA NPs of different PEG grafting density were well tolerated and exhibited no toxicity to RAW 264.7 cells as seen by cell proliferation assays. Cellular uptake of NPs was mainly dependent on polymer type as well as PEG grafting density. Grafted copolymer NPs resulted in lower degree of macrophage uptake compared to PLA NPs in macrophages cell lines. The higher the PEG grafting density, the lower the uptake of NPs by macrophage cells. Minimum NPs uptake for all the investigated concentrations was achieved when the PEG grafting density was 7% mol/mol of lactic acid. When increasing the PEG grafting density in the nanoparticles above 7%, no significant reduction in NPs phagocytosis was achieved. Thus, this study shows that the optimal PEG density required for designing stealth PEG-g-PLA NPs suitable for drug delivery applications might vary from 4 to 7%.
Read full abstract